Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation

Nephrology Dialysis Transplantation

Volumn 29, Issue 5, 2014, Pages 1097-1102

  Ledeganck, Kristien J ^a   De Winter, Benedicte Y ^a   Van Den Driessche, Annelies ^b   Jürgens, Angelika ^a   Bosmans, Jean Louis ^a,b   Couttenye, Marie M ^b   Verpooten, Gert A ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cyclosporine; epidermal growth factor; fractional excretion; magnesium; sodium

Indexed keywords

CREATININE; CYCLOSPORIN; EPIDERMAL GROWTH FACTOR; MAGNESIUM; MAGNESIUM ION; SODIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOWN REGULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOMAGNESEMIA; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SODIUM BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

CYCLOSPORINE; EPIDERMAL GROWTH FACTOR; FRACTIONAL EXCRETION; MAGNESIUM; SODIUM;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; CYCLOSPORINE; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MAGNESIUM; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SODIUM;

EID: 84899853190     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft498     Document Type: Article

References (39)

1. Mueller XM. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg 2004; 77: 354-362
2. Asai T, Nakatani T, Yamanaka S et al. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angio-tensin system independent mechanism. Transplantation 2002; 74: 784-791
3. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 2008; 22: 1-15
4. Miura K, Nakatani T, Asai T et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation 2002; 73: 340-347
5. Higgins R, Ramaiyan K, Dasgupta T et al. Hyponatraemia and hyperkalae-mia are more frequent in renal transplant recipients treated with tacroli-mus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transplant 2004; 19: 444-450
6. Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf 2005; 28: 763-788
7. Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616-1622
8. Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg (2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 2004; 15: 549-557
9. Barton CH, Vaziri ND, Martin DC et al. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med 1987; 83: 693-699
10. Navaneethan SD, Sankarasubbaiyan S, Gross MD et al. Tacrolimus-asso- ciated hypomagnesemia in renal transplant recipients. Transplant Proc 2006; 38: 1320-1322
11. Hoenderop JGJ, Bindels RJM. Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 2005; 16: 15-26
12. Groenestege WM, Thebault S, van der Wijst J et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007; 117: 2260-2267
13. Thebault Sp, Alexander RT, Tiel Groenestege WM et al. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009; 20: 78-85
14. Ikari A, Okude C, Sawada H et al. Down-regulation of TRPM6-mediated magnesium influx by cyclosporin A. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 333-343
15. Ledeganck KJ, Boulet GA, Horvath CA et al. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am J Physiol Renal Physiol 2011; 301: F486-F493
16. Wheatley HC, Datzman M, Williams JW et al. Long-term effects of cyclo-sporine on renal function in liver transplant recipients. Transplantation 1987; 43: 641-647
17. Kanbay M, Goldsmith D, Uyar ME et al. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 2010; 29: 280-292
18. Tsau Y, Chen C. Urinary epidermal growth factor excretion in children with chronic renal failure. Am J Nephrol 1999; 19: 400-404
19. Alperovich G, Maldonado R, Moreso F et al. Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies. Am J Transplant 2004; 4: 650-654
20. Sairanen J, Hotakainen K, Tammela TL et al. Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium. Urology 2008; 71: 630-633
21. Nielsen S, Nexo E, Christensen EI. Absorption of epidermal growth factor and insulin in rabbit renal proximal tubules. Am J Physiol 1989; 256: E55-E63
22. Olsen PS, Nexo E, Poulsen SS et al. Renal origin of rat urinary epidermal growth-factor. Regul Pept 1984; 10: 37-45
23. Li ZZ, Zhao ZZ, Liu XH et al. Prediction of the outcome of antenatal hy-dronephrosis: significance of urinary EGF. Pediatr Nephrol 2012; 27: 2251-2259
24. Grandaliano G, Gesualdo L, Bartoli F et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 2000; 58: 182-192
25. Popovtzer MM, Schainuck LI, Massry SG et al. Divalent ion excretion in chronic kidney disease: relation to degree of renal insufficiency. Clin Sci 1970; 38: 297-307
26. Musso CG, Juarez R, Vilas M et al. Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old. Int Urol Nephrol 2012; 44: 1559-1562
27. Arthur JM, Shamim S. Interaction of cyclosporine and FK506 with diuretics in transplant patients. Kidney Int 2000; 58: 325-330
28. Bantle JP, Nath KA, Sutherland DR et al. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 1985; 145: 505-508
29. Myers BD, Sibley R, Newton L et al. The long-term course of cyclospor-ine-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
30. Sandberg MB, Riquier AD, Pihakaski-Maunsbach K et al. ANG II provokes acute trafficking of distal tubule Na+-Cl(-) cotransporter to apical membrane. Am J Physiol Renal Physiol 2007; 293: F662-F669
31. van der Lubbe N, Lim CH, Fenton RA et al. Angiotensin II induces phos-phorylation of the thiazide-sensitive sodium chloride cotransporter independent of aldosterone. Kidney Int 2011; 79: 66-76
32. Mamenko M, Zaika O, Ilatovskaya DV et al. Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem 2012; 287: 660-671
33. Liu L, Duke BJ, Malik B et al. Biphasic regulation of ENaC by TGF-α and EGF in renal epithelial cells. Am J Physiol Renal Physiol 2009; 296: F1417-F1427
34. Schrier R.W. Manual of Nephrology. Philadelphia: Lippincott Williams and Wilkins, 2009
35. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100
36. Kratz A, Ferraro M, Sluss PM et al. Laboratory reference value. N Engl J Med 2004; 351: 1548-1563
37. Messing EM, Murphybrooks N. Recovery of epidermal growth-factor in voided urine of patients with bladder-cancer. Urology 1994; 44: 502-506
38. Steiner RW. Interpreting the fractional excretion of sodium. Am J Med 1984; 77: 699-702
39. Musso CG, Reynaldi J, Vilas M et al. Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people. Int Urol Nephrol 2010; 42: 273-277